Never an off the shelf solution, we construct the most appropriate study design and data source based on the needs of your project.
Our teams deliver optimised, robust studies, benefiting from diverse, comprehensive knowledge spanning all corners of RWE and beyond.
Combining practicality with bespoke time-saving innovations to generate evidence aligned to RWE recommendations, as efficiently as possible.
200+
Evidence generation projects
100+
Strategic evidence planning projects
50+
Clients
100+
Indications
Projects are delivered by our specialised team of statisticians
Costello Medical has more than 10 years of experience working across 40 different infectious diseases. We understand the huge impact they can have on health, at both the patient and population level.
Our specialised real-world evidence team in infectious disease modelling brings together our statistical and epidemiological expertise. This team combines our multi-disciplinary experience to deliver end-to-end support from data sourcing and expert modelling (forecasting, transmission models and treatment/vaccine validation) to clear scientific reporting.
Our RWE team can support you with evidence generation for a wide range of gaps, including:
Using our extensive experience in Market Access and HTA, our team help to devise a RWE generation plan that underpins your product’s value proposition. To support our client’s strategy, our RWE experts can:
Where bespoke evidence collection is required, we have a wide range of expertise and capability in primary data studies. We work with our clients to understand their specific needs and employ the most appropriate study design to comprehensively address your research question.
We offer a full study management service ensuring the smooth operation of your project, including:
Get in touch with Miranda Townsend, our Study Management Services Lead, for more information.
With our dedicated in-house Patient Engagement team, we are fully equipped to design and conduct studies to generate primary data. Our team partners with Patient Advocacy Groups to recruit study participants and ensure patient-centric research. Additionally, we can collaborate with panel recruitment vendors to recruit participants.
Where pre-existing data exists, our RWE experts can support clients to generate evidence and insights from secondary data studies. Our highly skilled team of Epidemiologists, Statisticians and Analysts can support throughout the project process, including:
High-quality RWE generation begins with selecting the best data source. We offer a full data source mapping service, identifying, characterising and critically assessing relevant sources, ensuring that all appropriate information is at your fingertips.
By strategically leveraging the most suitable data sources based on the research question in hand, we can efficiently produce high-quality, credible evidence that resonates with stakeholders.
Declan Summers, Costello Medical’s Deputy Head of Real-World Evidence, recently presented a webinar alongside Sheela Upadhyaya focusing on the evolving role of real-world evidence in drug development. This session explores the recent shift in how real-world evidence is viewed by the pharmaceutical industry, with manufacturers increasingly considering RWE as an end-to-end solution that can be utilised throughout the drug development process.
In June 2022, the UK National Institute for Health and Care Excellence (NICE) launched its real-world evidence (RWE) framework. Our RWE team was delighted to participate in the public consultation for the framework earlier this year and reflect on the potential impact it will have on the UK and global health technology assessment (HTA) landscape in this article.
